V. Laurence - Concepedia

Author

V. Laurence

Also Known As

V Laurence, V. Laurence, V. M. Laurence, V.M. Laurence, Virginia Laurence, Virginia M. Laurence, Virginia Marie Laurence

Publications

371

Citations

H-Index

Concepts

All Affiliations

Poole Hospital University College London Beatson West of Scotland Cancer Centre Addenbrooke's Hospital Guy's and St Thomas' NHS Foundation Trust

About

V. Laurence is an author at Poole Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	210
2	Health Sciences	3	3	90
3	Nursing	1	1	92
4	Gastroenterology	1	1	16
5	Immunology	1	1	12

V. Laurence

Publications

284

Citations

H-Index

Page 1

	Year	Citations
Breathlessness clinics within specialist palliative care settings can improve the quality of life and functional capacity of patients with lung cancer Juliet Hately, V. Laurence, Ann Scott, Palliative Medicine Pulmonary CareAdvanced Lung DiseaseCancer ManagementFunctional CapacityOutpatient Clinic	2003	92
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1) Richard Booton, Paul Lorigan, Heather Anderson, Annals of Oncology Mitomycin C/vinblastine/cisplatinMedicineMetronomic TherapyPhase Iii TrialClinical Trials	2006	64
IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer David Landau, Laura Hughes, Angela Baker, International Journal of Radiation OncologyBiologyPhysics	2016	43
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer John D. Fenwick, David Landau, Angela T. Baker, International Journal of Radiation OncologyBiologyPhysics	2019	17
Chemoradiotherapy with or without Induction Chemotherapy for Locally Advanced Pancreatic Cancer: a UK Multi-institutional Experience Roopinder Gillmore, V. Laurence, Sherif Raouf, Clinical Oncology Uk Multi-institutional ExperienceSurgical OncologyPancreatic CancerGastrointestinal OncologyMedicine	2010	16
Serum bone alkaline phosphatase and CA 549 in breast cancer with bone metastases E H Cooper, MA Forbes, AK Hancock, Biomedicine & Pharmacotherapy Breast OncologyBone HealthCa 549PathologyBreast Cancer	1992	16
Experience of first- and subsequent-line systemic therapy in the treatment of non-small cell lung cancer Bryony Eccles, T. Geldart, V. Laurence, Therapeutic Advances in Medical Oncology	2011	14
Use of mucin like cancer associated antigen (MCA) in the management of breast cancer V. Laurence, MA Forbes, E H Cooper British Journal of Cancer Tumor BiologyBreast OncologyMedicineCancer ManagementImmunology	1991	12
Phase II study of sequential docetaxel (Taxotere®, TXT) and doxorubicin (Dox) as primary chemotherapy (CT) for large operable breast cancer (BC) V. Laurence, V. Girre, J.M. Extra, European Journal of Cancer Surgical OncologyBreast OncologyMedicinePhase Ii StudyBreast Cancer	1999	10

Page 1